Showing results (1041-1050 of 1,322) with videos related to

Sort By:
Pageof 133
Current Problems in Cancer|August 30, 2021
Adjuvant Treatment Following Irradical Resection of Stage I-III Non-small Cell Lung Cancer: A Population-based StudyMarnix J A Rasing, Max Peters, Mieke J Aarts, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patientsJoost van der Hoek, Wouter W de Herder, Richard A Feelders, et al.
Journal of Lipid Research|September 5, 2007
APOA5 variants and metabolic syndrome in CaucasiansHarald Grallert, Eva-Maria Sedlmeier, Cornelia Huth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2017
Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine TumorsTessa Brabander, Wouter A van der Zwan, Jaap J M Teunissen, et al.
Nature Communications|February 19, 2026
Coronaviruses reprogram the tRNA epitranscriptome to favor viral protein expressionElena Muscolino, Mireia Puig-Torrents, Jaime Buigues Bisquert, et al.
Plos Pathogens|January 18, 2013
Schmallenberg virus pathogenesis, tropism and interaction with the innate immune system of the hostMariana Varela, Esther Schnettler, Marco Caporale, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2004
The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitroLeo J Hofland, Joost van der Hoek, Peter M van Koetsveld, et al.
The Journal of Clinical Endocrinology and Metabolism|June 3, 2017
Sorafenib-Induced Changes in Thyroid Hormone Levels in Patients Treated for Hepatocellular CarcinomaCarolien M Beukhof, Leni van Doorn, Theo J Visser, et al.
European Journal of Clinical Investigation|June 18, 2016
Leucocyte-bound apolipoprotein B in the circulation is inversely associated with the presence of clinical and subclinical atherosclerosisMarijke A de Vries, Boudewijn Klop, Noëlle van der Meulen, et al.
Pageof 133